Form 4 · Filed Jun 22, 2026, 08:02 PM UTC
GYRE/GYRE THERAPEUTICS, INC.
Ye Weiguo — Chief Operating Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
9 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | M | other | 3,000 | — | — | 827,701 |
| Jun 18, 2026 | M | other | 3,000 | $1 | $2,250 | 703,000 |
| Jun 18, 2026 | S | sell | 3,000 | $6 | $19,050 | 700,000 |
| Jun 10, 2026 | S | sell | 5,000 | $6 | $31,200 | 700,000 |
| Jun 10, 2026 | M | other | 5,000 | — | — | 830,701 |
| Jun 10, 2026 | M | other | 5,000 | $1 | $3,750 | 705,000 |
| Jun 9, 2026 | M | other | 3,000 | $1 | $2,250 | 703,000 |
| Jun 9, 2026 | M | other | 3,000 | — | — | 835,701 |
| Jun 9, 2026 | S | sell | 3,000 | $6 | $18,450 | 700,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001140361-26-025950